Company presentations 2025

Comprehensive characterization of protein impurities in cell and gene therapy products by mass spectrometry

ProtaGene GmbH

ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms including NBE, AAV, mRNA and LV development candidates. Our services comprise extended characterization as well as release and stability testing.

Name	Position	Institution
Daniel Waldera-Lupa	Associate Director Analytical Development	ProtaGene

https://www.protagene.com/

https://www.linkedin.com/company/protagene/about/